We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Surgeons Use Transplant Surgery to Remove Tumor

By HospiMedica staff writers
Posted on 09 Apr 2008
Surgeons in the United States used transplant surgery to first remove and then replace multiple abdominal organs in the same person so that they could reach and cut out a tumor in a female patient who had a rare form of cancer.

Surgeons at the University of Miami/Jackson Medical Center (UM/JMMC, FL, USA) undertook the 15-hour operation of 63-year old Brooke Zepp, who suffered from leiomyosarcoma, a rare type of tumor, which affects smooth muscle. More...
The tumor was deep inside her abdomen, wrapped around her aorta and two other arteries that supply blood to the abdominal organs, including the intestines. The patient had already been through chemotherapy and radiation treatment, but neither had been successful and the cancer had persisted. In most cases, the tumor would have been classed as inoperable.

The surgical procedure involved removing six organs--the stomach, pancreas, spleen, liver, and large and small intestines--from the abdomen to allow doctors to go after a malignant growth, which were continuously cooled following the excision. The tumor was then quickly removed, together with the blood vessels that were attached to it. The surgeons then replaced some of the removed sections of artery with artificial Gore-Tex blood vessels and proceeded to re-implant the removed organs back into the abdomen. The removed organs were outside of the body for about 90 minutes.

"It is very risky and definitely one of the most challenging surgeries of my career,” said lead surgeon transplant specialist Tomoaki Kato, M.D. "The patient is making a good recovery; she is considered cured at this point, but only time will prove its long-term efficacy.”


Related Links:
University of Miami/Jackson Medical Center

Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
VTE Prevention System
Flowtron ACS900
Absorbable Monofilament Mesh
Phasix Mesh
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The researchers grew pancreatic tissue (above) so it incorporated a mesh-like electronic network (red). Cells within the tissue produce insulin (green). (Photo courtesy of Penn Medicine)

‘Cyborg’ Transplants Could Replace Pancreatic Tissue Damaged by Diabetes

Type 1 diabetes destroys insulin-producing islet cells, forcing patients to rely on lifelong insulin therapy or scarce organ transplants. Although lab-grown pancreatic tissue offers a promising alternative,... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.